Adamas Pharmaceuticals, Inc. (ADMS)
Company Info
| ISIN | US00548A1060 |
|---|---|
| CUSIP | 00548A106 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
ADMSShare Price Chart
Click Calculate to get results
ADMSPerformance
The chart shows the growth of $10,000 invested in Adamas Pharmaceuticals, Inc. in Apr 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,867 for a total return of roughly -41.33%. All prices are adjusted for splits and dividends.
ADMSReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 2.62% | 3.44% |
| 6M | 64.73% | 12.26% |
| YTD | 89.84% | 25.17% |
| 1Y | 91.61% | 31.41% |
| 5Y | -12.54% | 16.37% |
| 10Y | -6.76% | 13.15% |
ADMSMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 36.49% | -19.63% | 1.05% | 17.50% | -1.95% | -4.52% | -9.47% | -1.46% | 4.25% | 65.17% | 1.36% | |
| 2020 | 35.62% | -11.28% | -36.62% | 11.76% | -14.55% | -7.25% | -3.13% | 108.87% | -20.46% | -26.21% | 49.01% | -4.42% |
| 2019 | 5.39% | 24.33% | -36.46% | -11.11% | -25.63% | 31.91% | 0.97% | 0.80% | -18.94% | -19.65% | 44.77% | -36.30% |
| 2018 | 11.66% | -35.39% | -2.25% | 26.32% | -5.13% | -9.81% | -7.94% | -3.15% | -13.07% | -17.33% | -38.13% | -16.60% |
| 2017 | -6.09% | 16.57% | -5.41% | -6.40% | -6.11% | 13.72% | -0.80% | 20.69% | 1.10% | 16.49% | 50.65% | -8.78% |
| 2016 | -39.48% | -25.32% | 12.97% | 16.74% | -0.36% | -9.99% | -0.26% | -9.47% | 20.04% | -16.27% | 9.17% | 12.67% |
| 2015 | -3.11% | 2.67% | 1.22% | -1.26% | 4.17% | 45.75% | -5.57% | -18.98% | -16.55% | -11.83% | 8.20% | 77.33% |
| 2014 | 31.69% | -3.25% | 2.41% | -12.96% | 17.79% | -0.64% | -18.21% | -3.55% | 18.24% |
ADMSDividend History
Adamas Pharmaceuticals, Inc. doesn't pay dividends
ADMSDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ADMSWorst Drawdowns
The table below shows the maximum drawdowns of the Adamas Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Adamas Pharmaceuticals, Inc. is 95.33%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.33% | Jan 24, 2018 | 541 | Mar 18, 2020 | — | — | — |
| -60.32% | Dec 24, 2015 | 218 | Nov 3, 2016 | 264 | Nov 21, 2017 | 482 |
| -55.27% | Jul 20, 2015 | 67 | Oct 21, 2015 | 44 | Dec 23, 2015 | 111 |
| -31.14% | May 2, 2014 | 153 | Dec 8, 2014 | 129 | Jun 15, 2015 | 282 |
| -14.59% | Dec 1, 2017 | 12 | Dec 18, 2017 | 20 | Jan 18, 2018 | 32 |
| -7.21% | Apr 11, 2014 | 1 | Apr 11, 2014 | 5 | Apr 21, 2014 | 6 |
| -4.36% | Jun 19, 2015 | 7 | Jun 29, 2015 | 5 | Jul 7, 2015 | 12 |
| -2.86% | Jul 8, 2015 | 1 | Jul 8, 2015 | 2 | Jul 10, 2015 | 3 |
| -1.81% | Apr 25, 2014 | 1 | Apr 25, 2014 | 2 | Apr 29, 2014 | 3 |
| -1.78% | Nov 27, 2017 | 1 | Nov 27, 2017 | 1 | Nov 28, 2017 | 2 |
ADMSVolatility Chart
Current Adamas Pharmaceuticals, Inc. volatility is 8.49%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.